Myeloma in the Real World: What Is Really Happening?


Multiple myeloma (MM) is the second most common hematologic malignancy and is predominantly a disease of the elderly. In the past 2 decades, a range of new therapeutic options have become available, leading to improvements in patient outcomes, including both attainment of remission and overall survival. These improved outcomes have heralded a paradigm shift… (More)
DOI: 10.1016/j.clml.2016.12.002